GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Retained Earnings

ME Therapeutics Holding (XCNQ:METX) Retained Earnings : C$-7.73 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. ME Therapeutics Holding's retained earnings for the quarter that ended in Feb. 2024 was C$-7.73 Mil.

ME Therapeutics Holding's quarterly retained earnings declined from Aug. 2023 (C$-7.24 Mil) to Nov. 2023 (C$-7.58 Mil) and declined from Nov. 2023 (C$-7.58 Mil) to Feb. 2024 (C$-7.73 Mil).

ME Therapeutics Holding's annual retained earnings increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$-0.72 Mil) but then declined from Aug. 2022 (C$-0.72 Mil) to Aug. 2023 (C$-7.24 Mil).


ME Therapeutics Holding Retained Earnings Historical Data

The historical data trend for ME Therapeutics Holding's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Retained Earnings Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Retained Earnings
-0.72 -7.24

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Retained Earnings Get a 7-Day Free Trial -3.90 -4.29 -7.24 -7.58 -7.73

ME Therapeutics Holding Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


ME Therapeutics Holding  (XCNQ:METX) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines